Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application PCT/US2014/054203, filed Sep 5, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,471,071 | Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis In force · High confidence UsedRemaining | Ellodi Pharmaceuticals, L.P. | In force | High confidence | ||
| US 11,166,961 | Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis In force · High confidence | Ellodi Pharmaceuticals, L.P. | In force | High confidence | ||
| US 11,260,061 | Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis In force · High confidence | Ellodi Pharmaceuticals, L.P. | In force | High confidence | ||
| US 12,310,976 | Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis In force · High confidence | Ellodi Pharmaceuticals, L.P. | In force | High confidence | ||
| US 12,447,157 | Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis In force · High confidence | Ellodi Pharmaceuticals, L.P. | In force | High confidence | ||
| Application 19/179,530 | Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis Pending Not granted | Ellodi Pharmaceuticals, L.P. | Pending | Not granted | ||
| Application 19/403,674 | Corticosteroid Containing Orally Disintegrating Tablet Compositions for Eosinophilic Esophagitis Pending Not granted | Adare Development I, L.P. | Pending | Not granted |
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Ellodi Pharmaceuticals, L.P..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.